कंपनी का अवलोकन
GoodRx Holdings, Inc. operates within the healthcare sector, specifically focusing on the health information services industry, where it provides consumers with digital tools to compare prescription drug prices and reduce out-of-pocket costs in the United States. The company manages a price comparison platform that curates geographically relevant data to facilitate savings for individuals purchasing medications. In terms of scale, the entity holds a market capitalization of $739.96M and generates annual revenue of $796.85M while employing 697 individuals. These financial dimensions suggest a mid-cap position in the health information services landscape, where the substantial market cap relative to revenue indicates a valuation that incorporates expectations of future operational leverage, while the employee count reflects a lean operational model typical for digital-first platforms in the healthcare sector.
वित्तीय स्वास्थ्य
The company reported revenue of $796.85M and net income of $30.44M for the trailing twelve months, with EBITDA standing at $122.31M. The significant disparity between the revenue figure and the net income reveals a cost structure where high operating expenses or non-operating costs consume a substantial portion of gross receipts before arriving at the bottom line. Free cash flow is recorded at $81.94M, which indicates that the company generates sufficient cash from its operations after capital expenditures to support liquidity needs, debt servicing, and potential strategic investments without relying on external financing. The gross margin stands at 92.8%, indicating a highly scalable software or service model with low variable costs, while the operating margin of 19.0% and profit margin of 3.8% demonstrate that operating expenses and other costs significantly impact the final profitability relative to sales. On the balance sheet, cash holdings of $261.82M are contrasted against total debt of $542.81M, resulting in a debt-to-equity ratio of 88.08, which suggests a leveraged balance sheet where debt obligations exceed equity capitalization. The current ratio of 2.61 signifies strong short-term liquidity, as current assets are more than double the current liabilities, providing a comfortable buffer against immediate financial obligations. Return on Equity is 4.5% and Return on Assets is 4.8%, metrics that reveal management effectiveness in generating returns from shareholders' equity and the total asset base, respectively, though these rates indicate that capital efficiency is moderate relative to the leverage present in the company's structure.
मूल्यांकन आकलन
The trailing twelve-month P/E ratio is 24.00, whereas the forward P/E is 5.88, a stark difference implying that the market expects earnings to recover significantly or that current earnings are temporarily suppressed due to the recent negative growth trajectory. The price-to-book ratio is 1.20, indicating that the stock trades at a slight premium over its book value, reflecting market confidence in the intangible assets and brand value of the price comparison platform. Additional valuation metrics include a price-to-sales ratio of 0.93 and an EV/EBITDA of 8.35, which suggest that the company is valued conservatively relative to its sales and earnings power when compared to industry peers. The stock has traded between a 52-week high of $5.81 and a 52-week low of $1.77, meaning the current price sits within a range that reflects significant volatility and a substantial retracement from recent peaks. With a beta of 1.47, the stock exhibits price volatility that is higher than the broader market, indicating that its price movements are more sensitive to general market fluctuations than the average equity in the S&P 500.
Growth & Income
Revenue growth year-over-year is -1.9%, while earnings growth year-over-year is -9.7%, indicating that earnings are contracting at a faster rate than revenue, which implies that the company is facing margin compression or increased cost pressures that are outpacing top-line expansion. As the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, all generated earnings are retained within the business to fund operations, pay down debt, or invest in technological growth rather than being distributed to shareholders. This reinvestment strategy is common for growth-oriented companies in the healthcare information sector that prioritize scaling their user base and platform capabilities over immediate income distribution. The overall growth and income profile is characterized by negative sequential expansion in both revenue and profitability, coupled with a lack of dividend income, presenting a high-risk, high-potential-recovery scenario for investors analyzing the asset.